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Mitochondrial dysfunction has been widely associated with the pathology of Alzheimer's disease, but
there is no consensus on whether it is a cause or consequence of disease, nor on the precise mechanism
(s). We addressed these issues by testing the effects of expressing the alternative oxidase AOX from Ciona
intestinalis, in different models of AD pathology. AOX can restore respiratory electron ﬂow when the
cytochrome segment of the mitochondrial respiratory chain is inhibited, supporting ATP synthesis,
maintaining cellular redox homeostasis and mitigating excess superoxide production at respiratory
complexes I and III. In human HEK293-derived cells, AOX expression decreased the production of beta-
amyloid peptide resulting from antimycin inhibition of respiratory complex III. Because hydrogen per-
oxide was neither a direct product nor substrate of AOX, the ability of AOX to mimic antioxidants in this
assay must be indirect. In addition, AOX expression was able to partially alleviate the short lifespan of
Drosophila models neuronally expressing human beta-amyloid peptides, whilst abrogating the induction
of markers of oxidative stress. Our ﬁndings support the idea of respiratory chain dysfunction and excess
ROS production as both an early step and as a pathologically meaningful target in Alzheimer's disease
pathogenesis, supporting the concept of a mitochondrial vicious cycle underlying the disease.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder
whose hallmark is the appearance and progressive accumulation
of amyloid-β (Aβ)-containing plaques and hyperphosphorylated
tau-containing neuroﬁbrillary tangles. Aβ peptide arises from the
aberrant processing of the amyloid precursor protein APP. Thus far,
no treatments for AD have succeeded, beyond producing marginal
symptomatic beneﬁts. Understanding the molecular and cellular
basis of the disease is therefore crucial to developing an effective
therapy.
Genetic causes of familial, early-onset AD that have been
identiﬁed include dominant mutations in the APP gene itself, as
well as in genes for two proteases involved in its processing,
presenilins 1 and 2 [1]. This supports the widely held view thatInc. This is an open access article u
logy, FI-00014 University of
obs).Aβ-associated proteotoxicity is a key step in pathogenesis. How-
ever, the exact roles of plaques (and tangles) in pathogenesis is the
subject of much debate, as is the primary underlying cause of their
production. Although genetic predisposition to the ‘sporadic’, late-
onset form of the disease is well established, the APOE (apolipo-
protein E) locus is the only one that appears to contribute sub-
stantially thereto [1].
A role for mitochondria in the aetiology of AD has often been
invoked. However, convincing proof of this is lacking. Many con-
tradictory hypotheses have been put forward, in which different
types of mitochondrial dysfunction are considered a fundamental
cause, a necessary step, a useful marker, a relevant consequence or
a pure epi-phenomenon, in regard to pathogenesis. Respiratory
chain deﬁciency in itself is far too inconsistent to be considered a
common pathological mechanism, e.g. see [2,3]. However, there is
more coherent evidence that oxidant species derived from mi-
tochondria are instrumental factors in the cellular dysfunction
underlying the disease [4]. Accordingly, the mitochondrially tar-
geted antioxidant MitoQ has been shown to enhance both
healthspan and lifespan in a transgenic Caenorhabditis elegansnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Hydrogen peroxide (H2O2) is the major, stable and freely dif-
fusible oxidant species present in cells. As well as giving rise to
even more potent oxidants, such as the hydroxyl radical via the
Fenton reaction, H2O2 is itself derived from the highly reactive
oxygen species (ROS) superoxide, produced in side-reactions by
the mitochondrial respiratory chain [6]. Indeed, the primary cel-
lular defence against superoxide is the enzyme superoxide dis-
mutase, which converts superoxide to peroxide. The ability to limit
mitochondrial H2O2 production would be of value in helping to
assess whether it is an underlying cause of Aβ deposition, a con-
sequence thereof, an exacerbating factor in Aβ-related AD pa-
thology, or mechanistically unrelated to the disease. Potentially it
could also be of value in designing future therapeutic approaches.
The alternative oxidase, AOX, is a non proton-motive, homo-
dimeric respiratory enzyme found in the mitochondria of plants,
fungi, microbes and some animal phyla [7–10]. By catalysing the
direct oxidation of ubiquinol by molecular oxygen, it is able to by-
pass the two terminal steps in the standard respiratory chain or
oxidative phosphorylation (OXPHOS) system, namely respiratory
complexes III (ubiquinol:cytochrome c oxidoreductase) and IV
(cytochrome c oxidase). The gene for AOX is absent from verte-
brates and arthropods. However, transgenic expression of the
Ciona intestinalis alternative oxidase (AOX) in human cells, Dro-
sophila or the mouse, which appears to be benign, supports mi-
tochondrial respiration in the presence of inhibitors of complexes
III or IV, such as antimycin or cyanide, respectively [11–14]. Under
such blockade, we observed that AOX expression greatly decreased
the otherwise substantial excess production of ROS. Furthermore,
even under non-inhibited conditions, mitochondrial ROS produc-
tion was diminished, the reasons for which are unclear, but may
indicate an inherent antioxidant activity of the enzyme.
The AOX is assumed to have a poor afﬁnity for its substrate,
ubiquinol, based on the fact that it is only activated when the
mitochondrial quinone pool is highly reduced [15]. Thus, under
most physiological conditions, AOX does not substantially compete
with respiratory complex III for ubiquinol oxidation. In addition,
by maintaining the mitochondrial quinone pool in a relatively
oxidized condition, AOX prevents excessive reduction of the re-
spiratory chain, which in turn minimizes the production of ex-
cessive superoxide by the mitochondria [16]. In plants, AOX is
therefore active in respiration whenever the cytochrome pathway
(complexes III and IV) is constrained by metabolic control [17,18],
or by the action of toxins [19]. In both cases, it acts as a molecular
safety-valve, allowing the plant to resist adverse environmental
conditions. Oxidative stress is often triggered under such condi-
tions, and AOX has been shown to play a central role in ROS and
NO homeostasis [20,21]. These properties should account for the
effects we observed in model organisms expressing Ciona AOX.
Confusingly, however, it has also been suggested that H2O2 rather
than water is the reaction product of AOX [22,23], which would
add to, rather than limit, the burden of oxidative stress. However,
under some conditions, AOX endowed with such properties might
also be postulated to use H2O2 as a substrate.
In this study, we used AOX as a tool to study the involvement of
mitochondrial pathways in AD pathology, notably the contribution
of ROS overproduction to the accumulation of Aβ and to the
downstream pathological consequences thereof. We found that
AOX expression signiﬁcantly decreased Aβ deposition by human
cells treated with the complex III inhibitor antimycin, and that this
correlated with decreased ROS production. As a corollary to this,
we conﬁrmed that water, not H2O2 is the reaction product of Ciona
AOX. Our ﬁndings support the concept that increased mitochon-
drial H2O2 production, resulting from chronic inhibition of the
cytochrome chain, is a key step in the pathogenesis of AD. In ad-
dition, AOX expression conferred a substantial increase in theshort lifespan of Drosophila strains also expressing Aβ, with con-
comitant abrogation of the induction of oxidative stress markers at
the RNA level. These ﬁndings imply that increased ROS production
due to inhibition of the cytochrome chain is also a physiologically
meaningful aspect of the pathological process unleashed by Aβ,
and place mitochondrial dysfunction as both an early and a late
step in AD pathogenesis, consistent with the operation of a vicious
cycle.2. Materials and methods
2.1. Human cell culture and transfection
Human Embryonic Kidney (HEK293) Flp-In cells (Invitrogen, St.
Quentin en Yvelines, France) were cultured in RPMI medium
containing 2 g/l glucose supplemented by 2 mM glutamine (as
Glutamax™), 10% foetal calf serum, 1 mM pyruvate, 100 mg/ml each
penicillin, streptomycin and zeocin (Invitrogen, St. Quentin en
Yvelines, France). HEK293 Flp-In cells were seeded in 12-well
plates to obtain 70% conﬂuence the following day, then co-trans-
fected in 1 ml of OptiMEM medium containing 4 ml Lipofectamine
2000, 1.2 mg of pOG44 Flp recombinase expression plasmid, and
0.13 mg pEF-1α/AOX plasmid containing the Ciona intestinalis AOX
cDNA [11]. After 5 h incubation, the medium was replaced by
DMEM medium devoid of zeocin. Two days later 150 mg/ml hy-
gromycin B were added in order to select for appropriate targeting
of constructs. Recombined cells bearing the AOX transgene inser-
tion were subsequently cloned by serial dilution.
2.2. Drosophila strains and maintenance
The Drosophila strains transgenic for Gal4-inducible Ciona in-
testinalis AOX (AOXF6) in the w1118 background [24] and for dif-
ferent human Aβ variants, also in the w1118 background [25] were
as described previously. The X-chromosomal elav-GAL4 driver line
(C155, Bloomington strain 458), as well as w1118 and standard
balancers for stock maintenance, were obtained from Bloomington
stock centre. Flies were maintained at 25 °C on standard medium
[26], except for lifespan measurements which were conducted as
described [25] at 29 °C, in vials containing batches of 20 ﬂies of a
given sex and genotype. Lifespan curves were based on combined
data from 4 to 8 such vials per sex and genotype, with ﬂies tipped
to fresh vials every 3 days, or on any day when dead ﬂies were
observed.
2.3. Cell growth assay
Cells were grown in DMEM containing 4.5 g/l glucose supple-
mented with 2 mM glutamine (as GlutamaxTM, Gibco Invitrogen,
Cergy Pontoise, France), 10% foetal calf serum, 2 mM pyruvate and
100 μg/ml penicillin/streptomycin. One million cells were seeded
in six-well plates for cell growth analysis. 24 h after seeding,
100 μM antimycin with or without 25 μM propyl gallate (PG) was
added and cell growth monitored at 0, 24 and 48 h. At least three
replicates of each treatment were used to calculate viability using
the Trypan blue exclusion assay.
2.4. Mitochondrial isolation
Enriched mitochondrial fractions from wild-type and AOX-
transgenic mouse [13] brains were prepared by differential cen-
trifugation. Brieﬂy, brains from three-month old mice were iso-
lated after dislocation. Blunt-ended scissors were used to cut the
brains into small pieces. These were transferred to a glass homo-
genizer with Teﬂon pestle and homogenized in ﬁve volumes of
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20 mM Tris/HCl, pH 7.2). The homogenate was centrifuged at
600gmax for 5 min. The supernatant was carefully recovered and
centrifuged at 10,000gmax for 10 min to pellet the mitochondria.
After discarding the supernatant, the pellet was resuspended in
1 ml of extraction buffer and re-centrifuged at 10,000 gmax for
10 min.
2.5. Polarography
Cell respiration and mitochondrial substrate oxidation were
polarographically estimated using a Clark oxygen electrode (Han-
satech Instruments, Norfolk, England) in a magnetically-stirred
chamber maintained at 37 °C in 250 μl of a respiratory medium
consisting of 0.3 M mannitol, 5 mM KCl, 5 mM MgCl2, 10 mM
phosphate buffer (pH 7.2) and 1 mg/ml bovine serum albumin,
plus substrates or inhibitors as described [27]. Substrate and in-
hibitor concentrations were as follows: 0.004% digitonin, 1 mM
ADP, 10 mM succinate, 50 mM PG, 1 or 10 mM KCN. Puriﬁed cat-
alase from beef liver (2 mg/ml; Sigma) was prepared in 10 mM
phosphate buffer (pH 7.2) and used at 3 IU ﬁnal concentration in
500 ml of assay medium, consisting of 1 mM phosphate buffer (pH
7.2), 5 mM MgCl2, 10 mM KCl and 0.3 M mannitol.
2.6. Western blotting
Western blot analyses were performed as indicated [12]. In
addition, blots were re-probed with an antibody against ATP
synthase subunit β (1:5000, rabbit polyclonal antibody, kindly
provided by A. Tzagoloff) as a standardization control. Peroxidase-
conjugated anti-rabbit secondary antibody (1:5000, Amersham,
Buckinghamshire, UK) and Western Lightning Ultra from Perki-
nElmer were used for detection.
2.7. Immunocytochemistry
HEK293-Flp-In cells expressing the AOX were seeded at
15,000 cells/cm2 and grown for 2 d in standard conditions on Lab-
Teks chambered coverglass (Nunc, Rochester, NY, USA). Cells were
then washed with phosphate buffer saline (PBS; Invitrogen, Saint
Quentin en Yvelines, France) and ﬁxed with 4% paraformaldehyde
for 20 min. They were permeabilized with 0.1% Triton X-100 (w/v)
for 5 min, washed 3 times with PBS and blocked with 5% goat
serum in PBS/0.05% Tween (w/v) for 30 min. After blocking, cells
were incubated for 2 h with a polyclonal antibody raised against
Ciona intestinalis AOX peptides (21st Century Biochemicals, Marl-
boro, MA, USA; [22]). Cells were then washed 3 times with PBS/
Tween, treated for 1 h with Alexa 562-conjugated anti-rabbit
secondary antibody (1000-fold dilution, Invitrogen, Cergy-Pon-
toise, France), washed again 3 times and mounted using Fluor-
escent mounting medium (Dako, Trappes, France) after 5 min in-
cubation with DAPI stain (Dako, Trappes, France). Fluorescence
was visualized using an eclipse TE300 microscope (Nikon, Cham-
pigny sur Marne, France). For simultaneous mitochondrial stain-
ing, 100 nM of Mitotrackers Red CMXRos dye (Life
TechnologiesTM) was added for 30 min at 37 °C prior to cell ﬁxa-
tion. Cells were then washed 3 times with PBS. This step was
followed by the aforementioned procedures.
2.8. Elisa
In order to detect the secreted soluble human Aβ40 peptide a
speciﬁc solid-phase sandwich enzyme-linked immuno-sorbent
assay (ELISA) was employed according to the instructions given in
the Abeta-ELISA kit by Invitrogen. Brieﬂy, cells were grown to 80%
conﬂuence, then for a further 24 h with or without additionaltreatment with antimycin (100 μM), rotenone (25 μM), ascorbic
acid (1 mM), tBQH (25 μM) and PG (50 mM), alone or in combi-
nation (see ). Cell supernatants were collected after a centrifuga-
tion step (400gmax for 5 min) after which ELISA was conducted,
whilst cell pellets were used for protein estimation.
2.9. RNA analysis
RNA extraction from 5 day-old Drosophila adult males cultured
at 29 °C and QRTPCR normalized to RpL32 as reference gene were
carried out as previously [24], using the following additional pri-
mer pairs (all sequences shown 5′ to 3′): Keap1-
TGCGTCGGCGGTTATTTATC and AGCATTCCTTTCCCCGTTGT, GstD1 –
TCAGCGCCTGTACTTCGACA and TCTTGAAGGCCTCTGGATCG, Hsp22
– CAATGCGTTCCTTACCGATG and GGTAGCGCCACACTCCAAAC, Sod2
– GCCCGTAAAATTTCGCAAAC and CGGCAGATGATAGGCTCCAG.
2.10. Statistical treatment
Except where indicated, data were analysed by one way ANOVA
using SigmaStat software (Sigma, St. Louis, USA). Data shown are
means71 SD. po0.001, 0.01 or 0.05 are denoted by ***, ** and *,
respectively. Non-signiﬁcant differences are denoted ns.3. Results
3.1. AOX mitigates the enhanced formation of Aβ40 by mitochondrial
ROS
It has been previously shown that increased mitochondrial ROS
production resulting from antimycin treatment leads to enhanced
Aβ formation in HEK293 cells [28]. Antimycin maintains the mi-
tochondrial ubiquinone pool in a highly reduced state by speciﬁ-
cally inhibiting respiratory complex III [29]. This condition favours
the formation of superoxide from oxygen-reactive semiquinone
free radicals. We ﬁrst established conditions of antimycin treat-
ment under which both AOX-expressing and control cells survived.
Flp-InTM T-RExTM-0293 cells induced to express the Ciona in-
testinalis AOX (Figs. 1A, 1B) showed approximately 60% cyanide-
resistance of succinate oxidation, which was abolished by further
treatment with propyl gallate (Fig. 1C). Both these cells and control
Flp-InTM T-RExTM-293 cells survived 24 h of antimycin treatment
(Fig. 1D), although control cells were killed by a further 24 h of
such exposure, whilst AOX-expressing cells continued to grow
(Fig. 1D). After 24 h of antimycin treatment, control cells showed a
2-fold increase in the production of the 40 amino-acid Aβ
peptide Aβ40, compared with untreated cells (Figs. 2A, 2B),
whereas the corresponding increase seen in AOX-expressing cells
was only 20%. Concomitant treatment with propyl gallate re-
stored the Aβ40 increase seen in control cells (Fig. 2A). AOX ex-
pression was more effective in limiting Aβ40 production than ei-
ther of two chemical antioxidants (Fig. 2B), ascorbic acid or tert-
Butylhydroquinone (food additive E319). It thus appears that the
AOX potently decreases Aβ40 production enhanced by respiratory
chain blockade at complex III.
3.2. The AOX product from oxygen reduction is water, not hydrogen
peroxide
The fact that AOX expression produced a similar effect as an-
tioxidant treatments appears inconsistent with the notion that
hydrogen peroxide could be its reaction product. However, it does
not exclude the possibility that the attenuation of Aβ40 production
was a hormetic effect, resulting from increased output of H2O2
triggering an increase in ROS detoxiﬁcation. Nor does it exclude
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a reverse reaction. To exclude completely the possibility that AOX
metabolism involves H2O2, we took advantage of the fact that
cyanide also inhibits catalase, but in a very different concentration
range than it does cytochrome c oxidase.
This is important, since catalase activity may mask the hy-
pothetical production or use of H2O2 by AOX. Any hydrogen per-
oxide produced by the AOX would be readily broken down by
catalase into oxygen and water [30,31], creating the illusion that
water is the real product of oxygen reduction by AOX, as well as
decreasing the amount of oxygen that appears to be consumed
when AOX is functioning [32]. The differential sensitivity to cya-
nide of cytochrome c oxidase (Ki o0.3 mM; [32]) and of catalase
(Ki about 10 mM; [30,31]) allowed us to rule out this possibility.
In a test assay, the activity of puriﬁed bovine liver catalase was
only 60% inhibited by 1 mM KCN (Fig. 3, traces A, B), whereas
10 mM KCN brought about almost complete inhibition of the en-
zyme (Fig. 3, trace C). In contrast, 1 mM KCN was sufﬁcient to fully
inhibit succinate oxidation by wild-type mouse brain mitochon-
dria, as expected (not shown). Oxygen consumption by brain mi-
tochondria from mice expressing AOX [13] was then tested in the
presence of various substrates and inhibitors. After initially sup-
plying succinateþADP as substrate, the rate of oxygen consump-
tion was maximized by the addition of the uncoupler m-Cl-CCP
(Fig. 3, traces D, E). Inhibition of cytochrome oxidase with 1 mM
KCN (Fig. 3, trace D) decreased oxygen uptake by 30%, while a
subsequent addition of propyl gallate fully abolished it, conﬁrming
that the residual oxygen consumption was AOX-dependent. Under
this condition (1 mM KCN), the subsequent addition of hydrogen
peroxide resulted in a rapid oxygen release attributable to catalase
activity. A similar experiment was next carried out, but using
10 mM KCN (Fig. 3, trace E). The same sequence of additions
produced almost identical results, except for the oxygen release
after hydrogen peroxide addition, which was totally abolished due
to catalase inhibition. Most importantly, no difference in oxygen
uptake was seen in the presence of 1 or 10 mM cyanide, indicating
that hydrogen peroxide is neither a product nor a substrate for C.
intestinalis AOX. Its anti-oxidant function must therefore be in-
direct, as is generally accepted also to be the case in plants [33–35].3.3. AOX expression increases the short lifespan of Drosophila ex-
pressing human Aβ in neurons
The fact that AOX expression mitigates the increase in Aβ
production due to respiratory chain inhibition leaves open the
question of whether Aβ production may also have a detrimental
effect on mitochondrial functions. This would potentially initiate a
vicious cycle of damage, as suggested by previous studies in-
dicating that oxidative stress [36] and mitochondrial dysfunction
[37] are consequences of Aβ deposition. To test this, we made use
of a set of Drosophila models expressing human Aβ peptides in
neurons [25] under the control of the pan-neuronal driver elav-
GAL4 at elevated temperature (29 °C). These models exhibit a de-
generative phenotype, with drastically shortened life-span and
mitochondrial dysfunction [38]. Neuronal toxicity is believed to be
mediated by intracellular accumulation of Aβ aggregates [25].
As noted previously [25] these models exhibit different degrees
of phenotypic severity (Fig. 4), in descending order, as follows: the
Arctic E22G variant of Aβ42 (AlzArc2)4wild-type Aβ42 on each of
chromosomes 2 and 3 (Alz42.2, Alz42.3)4one copy of Aβ42
(Alz42.3 only)4Aβ40 (Alz40.3)4no transgene (w1118 background
only). Flies expressing the Arctic Aβ42 variant died within
2 weeks, whereas Aβ40 produced hardly any decrease in lifespan
compared with the background strain. Males showed slightly
shorter lifespans than females in each case, with some experi-
ment-to-experiment variation due to the temperature-sensitivity
of the phenotype.
Co-expression of AOX produced a clear improvement in Aβ
mutant phenotypes (Fig. 4), although the magnitude of this effect
again varied between experiments, was stronger in females than
males, and was more pronounced for the severe mutants AlzArc2
and Alz42.2/Alz42.3. AOX alone on otherwise wild-type ﬂies in the
w1118 background produced no effect on lifespan.
3.4. AOX attenuates the expression of oxidative stress markers eli-
cited by human Aβ expression in Drosophila neurons
The observed AOX-driven rescue in Drosophila Aβ-expressing
models raises the question as to mechanism. In order to test
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Fig. 5. AOX abrogates induction of oxidative stress markers in a Drosophila AD model. Relative mRNA levels of genes as shown, based on QRTPCR normalized against RpL32,
in adult males of the indicated genotypes. Asterisks indicate data classes signiﬁcantly different from controls (AlzArc2 ﬂies without driver, white bars; Student's t test,
po0.05) except for Hsp22, where the difference from control ﬂies was just outside the border of signiﬁcance, but the indicated comparison was signiﬁcant.
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produced by respiratory chain inhibition, we measured the ex-
pression, at the RNA level, of several markers of oxidative stress,
including Hsp22 [39], GstD1 [40,41], Keap1, a negative regulator of
Nrf2-driven oxidative stress signaling that is itself induced by Nrf2
[42], and Sod2, an enzyme crucial for responses to oxidative stress,
but which is dispensable in the brain [43]. Since the expression of
both AOX and human Aβwas targeted uniquely to neurons, i.e. to a
minority of the ﬂy's tissues, and to minimize confounding effects
from oogenesis (which can affect the levels of housekeeping genes
such as Gapdh or RpL32, that are prominently expressed in oo-
cytes), we conﬁned the analysis to males, and to the Aβ variant
giving the strongest phenotype, i.e. AlzArc2, in 5 day-old adults.
Based on QRTPCR (Fig. 5), three of the four genes tested showed
upregulation in the AlzArc2 strain, with a signiﬁcant protective
effect from co-expression of AOX. No such effect was seen with
Sod2.4. Discussion
Our ﬁndings are consistent with a role for mitochondrial dys-
function in both the early and late steps of AD pathogenesis,
namely by enhancing Aβ peptide production, as well as a me-
chanism of pathological neurotoxicity caused by Aβ. Thus they
support the concept of a vicious cycle of mitochondrial damage as
a crucial disease process.
Mitochondrial involvement in AD is plagued by contradictory
ﬁndings, by the use of diverse and not always appropriate models,
and by the fact that pathological ﬁndings in AD patients typically
represent a late stage of the disease where primary and secondary
effects are hard to distinguish. As indicated above, the ﬁndings
linking inhibition of mitochondrial OXPHOS to AD pathology are
typical of such inconsistencies, despite the obvious attraction of
ATP depletion as a mechanism for impaired proteostasis. A large
body of literature indicates decreased activity of cytochrome c
oxidase and other mitochondrial enzymes in AD e.g. [2,37,44–47],
whereas other studies show an increase in mitochondrial com-
ponents [48]. These ﬁndings can potentially be reconciled if it is
assumed that the latter are mitochondrial degradation products,
and that mitochondrial turnover might itself be impaired in the
disease [48]. However, most such studies do not convincingly
distinguish mitochondrial damage from being the cause or the
consequence of AD pathology, and do not address the issue of
whether ATP deﬁcit and/or increased ROS production and con-
sequent oxidative stress are the underlying mechanism.
In the work reported here we based our initial experiments on
the ﬁndings of a previous study [28] in which Aβ production in
cells was shown to be enhanced by the administration ofantimycin, an inhibitor of mitochondrial respiratory complex III, as
well as by rotenone, an inhibitor of complex I. Both drugs lead to
large increases in mitochondrial ROS production. Mitochondrial
ROS has elsewhere been implicated in the pathway leading to
increased Aβ production due to hypoxia [49] or treatment with
oxidants [50]. In principle, our observation that AOX can block
increased Aβ production in the presence of antimycin could reﬂect
one or more of several properties of the enzyme, including the
(direct or indirect) alleviation of oxidative stress, an increased
capacity for ATP production or the restoration of other aspects of
cellular redox and metabolic homeostasis. Although we excluded a
direct enzymatic effect on H2O2 levels, as well as any hormetic
effect due to increased H2O2 output (which was not detectable), an
indirect effect of AOX on mitochondrial superoxide production
seems to be the most parsimonious interpretation of our ﬁndings.
By releasing respiratory chain blockade, AOX restores the normal
oxidized condition of the mitochondrial ubiquinone pool, as well
as upstream redox couples and, as shown previously, thus abol-
ishes the increase in ROS production following antimycin treat-
ment [12]. Previous studies suggested that ROS activates Aβ pro-
duction in this context by virtue of effects on the expression of
proteases involved in APP processing [49,50].
However, we cannot exclude the possibility that AOX may exert
its effect at least partially by boosting cellular ATP supply. In
plants, AOX activation can be functionally associated with co-ac-
tivation of the rotenone-resistant non-proton motive NADH de-
hydrogenase, by-passing ATP production completely [51]. How-
ever, when Ciona AOX is expressed in animal cells, ATP synthesis is
supported by complex I, which performs proton-motive CoQ re-
duction even in the functional absence of the cytochrome chain
[12]. Thus, by allowing electron ﬂow to resume, AOX indirectly
supports ATP production via proton pumping at the level of
complex I. Many aspects of protein metabolism, including folding/
refolding and proteolysis, are ATP-requiring. Thus, increased ATP
supply, even just locally, may inﬂuence the production or turnover
of Aβ.
Note that, because Ciona AOX is here expressed xenotopically
in mammalian cells not naturally endowed with AOX, and is active
whenever the cytochrome chain is blocked, any physiological
post-translational regulation of the enzyme, such as is well es-
tablished in plants [10], is most unlikely to be operative. However,
any loss of post-translational regulation is not crucial for activity
under our conditions.
Most literature relating mitochondrial dysfunction to AD pa-
thology has focused on mitochondria as a target rather than a
source of primary oxidative damage, and/or a mechanism by
which Aβ brings about a neurotoxic outcome. Mitochondrial dys-
function has been reported as an early feature of AD-related pa-
thology in various models, such as in mice expressing human Aβ
R. El-Khoury et al. / Free Radical Biology and Medicine 96 (2016) 57–6664[52,53]. Our ﬁnding that AOX can substantially increase the cur-
tailed lifespan of ﬂies expressing human Aβ in the nervous system
supports the proposition that the neurotoxicity of Aβ is mediated
by interference with electron ﬂow through the cytochrome seg-
ment of the respiratory chain. The effect of AOX appeared to be
more substantial in females than males, and in the models ex-
periencing the most damaging effects of Aβ, i.e., the Arctic variant
of Aβ42, or the doubly hemizygous strain expressing wild-type
Aβ42. Note that the beneﬁcial effect of AOX expression cannot be
explained by promoter dilution: the point has already been ad-
dressed previously in regard to other phenotypes [14,24]. In the
AD models used here, the second Aβ42 transgene in the doubly
hemizygous strain produced roughly twice the decrease in lifespan
seen in the strain expressing a single copy of Aβ42, indicating that
any promoter dilution effect is negligible.
Diminished electron ﬂow through both complex I and III has
been previously reported to occur as a result of Aβ expression. The
fact that AOX, which by-passes complexes III and IV, but not
complex I, can alleviate the pathological phenotype in the ﬂy
model, suggests that damage to complexes III and/or IV may be
more pathologically relevant. However, it will be interesting to
conduct an analogous series of experiments to by-pass cI, using
the non proton-motive NADH dehydrogenase from yeast (Ndi1) or
Ciona (NDX, [54]), both alone or in combination with AOX. This
would be able to determine whether Aβ peptides also affect cI
activity directly and, if so, whether the effects on cI and on
cIIIþcIV are additive or synergistic.
Note that, in previous studies, we observed that ubiquitous
expression of AOX had no effect on the lifespan of otherwise wild-
type ﬂies maintained at 25 °C [55], whereas ubiquitous expression
of Ndi1 did extend lifespan [26]. In a separate study, an increased
lifespan was reported in the case of Ndi1 expressed speciﬁcally in
neurons, using the drug-inducible GeneSwitch system, in ﬂies
maintained at 25 °C [59]. In the present study, expression of AOX
in neurons (without the use of drug induction) had almost no
effect on lifespan of control ﬂies at 29 °C, in the w1118 background
(Fig. 4). Thus, any confounding effect from transgenic expression of
the respiratory chain enzymes per se can be discounted.
Once again, the physiological mechanism by which AOX res-
cues the pathological phenotype in the ﬂy AD models remains
open: restored redox homeostasis, decreased ROS production and
increased ATP supply are all plausible. A recent report found that
MitoQ, an agent that quenches mitochondrial ROS, was able par-
tially to rescue pathological phenotypes, including curtailed life-
span, due to human Aβ expression in C. elegans [5]. It should be
noted that, in the latter study, transgenic Aβ was expressed in the
body muscle wall, whereas the Drosophila model that we em-
ployed targets Aβ to neurons. The pathological mechanism may
differ in the two cases, although the Drosophila model is arguably
more physiologically relevant to AD in humans.
The induction, in the AlzArc2 model, of genes known to med-
iate and be responsive to oxidative stress, plus its negation when
AOX was co-expressed (Fig. 5) provides strong supporting evi-
dence that increased mitochondrial ROS production is the key
pathological mechanism, at least in this model, and is consistent
with the proposition that AOX acts by alleviating ROS production
due to the build-up of over-reduced electron carriers in the re-
spiratory chain. The lack of signiﬁcant induction of the superoxide
dismutase Sod2, whilst superﬁcially surprising, ﬁts to previous
literature: tissue-speciﬁc RNAi knockdown experiments showed
that Sod2 is required in muscle, but non-essential in the brain [43].
Although its ectopic over-expression is beneﬁcial in various stress
models, e.g. [56,57], including one of tau-induced neurodegen-
eration, Sod2 has not, to our knowledge, been reported as being
transcriptionally induced under stress in Drosophila, consistent
with the data reported here. Even its enzymatic activity is onlyslightly induced by oxidative stress in the ﬂy [58]. Two caveats
nevertheless apply to our ﬁnding. Firstly, the tissue(s) in which
oxidative stress markers are induced in response to Aβ expression
in neurons, are not yet identiﬁed, so the effect could still be in-
direct. Secondly, an effect on ROS production and its mitigation
does not exclude the possibility that contributions from other
cellular or metabolic consequences of Aβ and AOX expression are
material to the phenotype.
Our ﬁndings are consistent with earlier observations that
suppressors of the Fenton reaction (over-expression of catalase or
of the heavy or light chains of the iron-binding protein ferritin)
alleviate the phenotypes of the same set of Drosophila AD models
[38], with increases in median lifespan of up to 60%. In the latter
study, over-expression of the cytosolic Cu/Zn superoxide dis-
mutase (Sod1) potentiated the pathological phenotype, whereas
over-expression of Sod2, or Sod1 knockdown by RNAi or expres-
sion of a dominant-negative Sod1 were all suppressive. Taken to-
gether with these ﬁndings, our results strongly implicate excess
mitochondrial ROS production, due to dysfunction of the re-
spiratory chain, as a pathological mechanism of Aβ neurotoxicity.
Several recent studies have indicated that the involvement of
mitochondria in the pathogenesis of AD may involve altered in-
teractions between the mitochondria and a speciﬁc sub-com-
partment of the endoplasmic reticulum (ER), the mitochondria-
associated membranes (MAMs). The resulting ER stress and dys-
regulated lipid metabolism are proposed to lead to abnormal
proteolysis, favouring the generation of the more pathogenic
forms of Aβ [60,61]. Oxidative stress due to mitochondrial dys-
function may be the initial trigger for these events. This concept is
consistent with our ﬁnding that Aβ production is increased by
respiratory chain dysfunction in a way that is suppressible by AOX.
ER dysfunction has been postulated not only as an underlying
cause of increased Aβ production, but also as one of the effects of
its accumulation [62–64]. Our data imply a similar vicious cycle of
cellular damage operating in the mitochondria. The intimate
functional connections between mitochondria and the ER leave
open the possibility that both organelles are involved in this
process.
The present study employs AOX to address aspects of the mo-
lecular mechanisms of AD pathogenesis, rather than to test its
possible applications in therapy, which is clearly a distant pro-
spect. Therapeutic delivery of AOX would be a major challenge,
requiring a genetic approach. On the other hand, once these issues
would be solved, AOX might become attractive as a minimally
invasive type of treatment. It requires no externally applied reg-
ulation, instead operating as a ‘pressure-relief’ valve that is only in
play when the cytochrome chain is unavailable.Acknowledgements
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